The purpose of this no cost modification is to: 1. Incorporate hhsar clause 352.232-71 - electronic submission of payment requests (FEB 2022), into section i of the contract 2. Update invoice…
Ended Awarded Last action
- Contract number
- HHSO100201600004I
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 12 $62,362,830 obligated
Award facts
- Opportunity
-
- 15100SOL00003 Solicitation number
- MCMs for Pandemic Influenza Preparedness and Response Award Notice · Posted Oct 14, 2016
- Medical Countermeasures for Pandemic Influenza Preparedness and Response Award Notice · Posted Dec 18, 2014
- Medical Countermeasures for Pandemic Influenza Preparedmess and Response Award Notice · Posted Oct 2, 2014
- Combined order value
- $62,362,830 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 3% used
- $2,113,742,425.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded an indefinite delivery contract to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to provide a range of pharmaceutical products and services under the Pandemic Influenza Preparedness and Response 2016-2021 program. The $2.11 billion multiple award contract has no set-aside designation and supports government efforts for disease prevention, immunization, drug stockpiling, and developing medical countermeasures like vaccines and antivirals. Task orders issued under this IDIQ contract include the delivery of influenza vaccine adjuvants, manufacturing of influenza vaccine antigens, storage and stability testing of vaccine stockpiles, and clinical studies for an H7N9 influenza vaccine. Glaxosmithkline will perform the contracted work at its facilities in Research Triangle Park, North Carolina. This contract and associated task orders aim to bolster the government's preparedness and response capabilities for pandemic influenza and other public health emergencies.
Glaxosmithkline has extensive experience providing pharmaceutical products and services to federal agencies, including the Departments of Defense, Veterans Affairs, Health and Human Services, and others, through both contracts and grants. The company has supplied a variety of vaccines, antiviral medications, and other medical countermeasures to support disease prevention efforts, immunization programs, correctional healthcare, and strategic national stockpiling initiatives. This IDIQ contract with ASPR allows the government to acquire these types of critical pharmaceutical goods and services on an as-needed basis to meet evolving public health preparedness requirements.
Description
The purpose of this no cost modification is to: 1. Incorporate hhsar clause 352.232-71 - electronic submission of payment requests (FEB 2022), into section i of the contract 2. Update invoice submission instructions in section g.5 by signing
Task orders
Show all 12
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract HHSO100201600004I?
HHSO100201600004I was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 22, 2016.
How much is contract HHSO100201600004I worth?
Orders under HHSO100201600004I have obligated $62,362,830. HHSO100201600004I's own ceiling is $2,113,742,425.
How many orders have been placed under contract HHSO100201600004I?
12 orders have been placed under HHSO100201600004I, the latest on September 1, 2020.
Who can order from contract HHSO100201600004I?
HHSO100201600004I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSO100201600004I part of a contract vehicle?
Yes. HHSO100201600004I is part of Pandemic Influenza Preparedness and Response 2016-2021.
Was contract HHSO100201600004I competed?
The extent of competition for HHSO100201600004I was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV